Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Complex Congenital Heart Defect clinical trials
1 of 4 indexed Complex Congenital Heart Defect trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Complex Congenital Heart Defect: 4 US clinical trials tracked, 1 recruiting.
Complex Congenital Heart Defect is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Edwards Lifesciences, running 3 of these trials.
Enrollment posture brief
Registry condition complex-congenital-heart-defect
OPEN 1 | RECR 25% | LATE 0 | EARLY 0 | RANK #4115 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Complex Congenital Heart Defect lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Complex Congenital Heart Defect on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Complex Congenital Heart Defect is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Edwards Lifesciences
NCT02744677
ALTERRA Post-Approval Study
Edwards Lifesciences
NCT05378386
COMPASSION S3 Post-Approval Study
Edwards Lifesciences
NCT04860765
Neurodevelopment in Infants With Complex Congenital Heart Defects
Ohio State University
NCT03104751
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Complex Congenital Heart Defect records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Complex Congenital Heart Defect trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Complex Congenital Heart Defect page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Complex Congenital Heart Defect trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Edwards Lifesciences sponsors the most Complex Congenital Heart Defect trials on record, review their full trial history before evaluating a specific study. See Edwards Lifesciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Complex Congenital Heart Defect condition card totals 4 registered trials; most-linked intervention Sapien 3 THV; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.